Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Oral and Maxillofacial Surgery
Published in: Oral and Maxillofacial Surgery 2/2019

01-06-2019 | Alopecia | Review Article

Alopecia and techniques in hair restoration: an overview for the cosmetic surgeon

Authors: Rohan Joshi, Tom Shokri, Austin Baker, Scott Kohlert, Mofiyinfolu Sokoya, Sameep Kadakia, Jeffrey Epstein, Yadranko Ducic, R. Michael Johnson

Published in: Oral and Maxillofacial Surgery | Issue 2/2019

Login to get access

Abstract

Purpose

Alopecia is a debilitating disorder affecting millions of individuals worldwide. Although challenging to treat, advances in hair restoration technologies have led to multiple viable options with excellent clinical results. This paper seeks to provide an overview of hair loss and the currently utilized techniques in hair transplantation in order to serve as a reference source for the facial plastic surgeon.

Methods

A comprehensive review of recent literature regarding the evaluation of, and management modalities for, alopecia was performed.

Results

The follicular unit extraction technique and the strip harvest technique are both widely used for patients desiring transplantation. While both techniques can lead to successful outcomes, each has pros and cons that are important to understand prior to engaging in the procedure.

Conclusion

Advancements in hair restoration technologies implementing robotics, manual, or motorized follicular unit extraction have facilitated optimization of outcomes. Adjuvant treatment modalities including robotics and platelet-rich plasma injections have shown utility in augmenting transplantation.
Literature
1.
Rhodes T, Girman CJ, Savin RC et al (1998) Prevalence of male pattern hair loss in 18-49 year old men. Dermatol Surg 24:1330–1332PubMed
2.
Stough D, Stenn K, Haber R et al (2005) Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc 80:1316–1322CrossRefPubMed
3.
Banka N, Bunagan MJ, Shapiro J (2013) Pattern hair loss in men: diagnosis and medical treatment. Dermatol Clin 31:129–140CrossRefPubMed
4.
Birch MP, Messenger JF, Messenger AG (2001) Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 144:297–304CrossRefPubMed
5.
Blume-Peytavi U, Blumeyer A, Tosti A et al (2011) S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 164:5–15CrossRefPubMed
6.
Muller M, Jasmin JR, Monteil RA, Loubiere R (1991) Embryology of the hair follicle. Early Hum Dev 26:159–166CrossRefPubMed
7.
Olsen EA, Dunlap FE, Funicella T et al (2002) A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 47:377–385CrossRefPubMed
8.
Jahoda CA (1998) Cellular and developmental aspects of androgenetic alopecia. Exp Dermatol 7:235–248PubMed
9.
Rousso DE, Kim SW (2014) A review of medical and surgical treatment options for androgenetic alopecia. JAMA Facial Plast Surg 16:444–450CrossRefPubMed
10.
Brockschmidt FF, Hillmer AM, Eigelshoven S et al (2010) Fine mapping of the human AR/EDA2R locus in androgenetic alopecia. Br J Dermatol 162:899–903CrossRefPubMed
11.
Yip L, Rufaut N, Sinclair R (2011) Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know. Australas J Dermatol 52:81–88CrossRefPubMed
12.
13.
Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247–254CrossRefPubMed
14.
15.
Leal-Osuna SE, Becerril-Parra DE, Tinoco-Fragoso F, Garcia-Gil AB, Vega-Memije ME, Lammoglia-Ordiales L (2018) Clinical, trichoscopic, and histopathologic characteristics of patients with alopecia and hypothyroidism: an observational study. J Am Acad Dermatol 79:958–960CrossRefPubMed
16.
Asik M, Binnetoglu E, Sen H, Tekeli Z, Uysal F, Ukinc K (2013) Graves’ disease associated with alopecia areata developing after Hashimoto’s thyroiditis. J Nippon Med Sch 80:467–469CrossRefPubMed
17.
18.
Katoulis AC, Diamanti K, Sgouros D et al (2017) Frontal fibrosing alopecia and vitiligo: coexistence or true association? Skin Appendage Disord 2:152–155CrossRefPubMed
19.
Trueb RM, El Shabrawi-Caelen L, Kempf W (2017) Cutaneous lupus erythematosus presenting as frontal fibrosing alopecia: Report of 2 patients. Skin Appendage Disord 3:205–210CrossRefPubMedPubMedCentral
20.
House NS, Welsh JP, English JC 3rd (2012) Sarcoidosis-induced alopecia. Dermatol Online J 18:4PubMed
21.
Oremovic L, Lugovic L, Vucic M, Buljan M, Ozanic-Bulic S (2006) Cicatricial alopecia as a manifestation of different dermatoses. Acta Dermatovenerol Croat 14:246–252PubMed
22.
Asz-Sigall D, Gonzalez-de-Cossio-Hernandez AC, Rodriguez-Lobato E, Ortega-Springall MF, Vega-Memije ME, Arenas Guzman R (2016) Linear lichen planopilaris of the face: case report and review. Skin Appendage Disord 2:72–75CrossRefPubMedPubMedCentral
23.
Sankar J, Raj D, Sankar J, Sharma PK, Lodha R, Kabra SK (2007) HIV infection mimicking autoimmune disorder. Indian J Pediatr 74:777–780CrossRefPubMed
24.
Sood I, Kasundra GM, Supriya PS, Gupta A, Bhushan B (2015) A rare case of occult abdominal tuberculosis with Poncet’s disease mimicking adult onset Still’s disease. J Midlife Health 6:125–128PubMedPubMedCentral
25.
Doche I, Hordinsky MK, Valente NYS, Romiti R, Tosti A (2017) Syphilitic alopecia: case reports and trichoscopic findings. Skin Appendage Disord 3:222–224CrossRefPubMedPubMedCentral
26.
27.
28.
29.
Haider M, Hamadah I, Almutawa A (2013) Radiation- and chemotherapy-induced permanent alopecia: case series. J Cutan Med Surg 17:55–61CrossRefPubMed
30.
Rogers NE, Avram MR (2008) Medical treatments for male and female pattern hair loss. J Am Acad Dermatol 59:547–566CrossRefPubMed
31.
Tsuboi R, Itami S, Inui S et al (2012) Guidelines for the management of androgenetic alopecia (2010). J Dermatol 39:113–120CrossRefPubMed
32.
Dawber R, Rundegren J (2003) Hypertrichosis in females applying minoxidil topical solution and in normal controls. J Eur Acad Dermatol Venereol 17:271–275CrossRefPubMed
33.
Schweiger ES, Boychenko O, Bernstein RM (2010) Update on the pathogenesis, genetics and medical treatment of patterned hair loss. J Drugs Dermatol: JDD 9:1412–1419PubMed
34.
Kaufman KD, Olsen EA, Whiting D et al (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39:578–589CrossRefPubMed
35.
Roberts JL, Fiedler V, Imperato-McGinley J et al (1999) Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol 41:555–563PubMed
36.
Iorizzo M, Vincenzi C, Voudouris S, Piraccini BM, Tosti A (2006) Finasteride treatment of female pattern hair loss. Arch Dermatol 142:298–302CrossRefPubMed
37.
Yeon J, Jung J, Choi J et al (2011) 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss. J Eur Acad Dermatol Venereol 25:211–214CrossRefPubMed
38.
Amory JK, Wang C, Swerdloff RS et al (2007) The effect of 5α-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab 92:1659–1665CrossRefPubMed
39.
Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S (2004) Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor. J Clin Endocrinol Metab 89:2179–2184CrossRefPubMed
40.
Hamblin MR, Demidova TN Mechanisms of low level light therapy Mechanisms for low-light therapy: International Society for Optics and Photonics. 2006:614001
41.
42.
Leavitt M, Charles G, Heyman E, Michaels D (2009) HairMax LaserComb® laser phototherapy device in the treatment of male androgenetic alopecia. Clin Drug Investig 29:283–292CrossRefPubMed
43.
Greco J, Brandt R (2007) Preliminary experience and extended applications for the use of autologous platelet-rich plasma in hair transplantation surgery. Hair Transplant Forum Int:131–132
44.
Uebel CO, da Silva JB, Cantarelli D, Martins P (2006) The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg 118:1458–1466CrossRefPubMed
45.
Li ZJ, Choi HI, Choi DK et al (2012) Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 38:1040–1046CrossRefPubMed
46.
Reese R (2008) A single-blinded, randomized controlled study of the use of autologous platelet rich plasma (PRP) as a medium to reduce scalp hair transplant adverse effects. Hair Transplant 18:51–52
47.
Limmer BL (1994) Elliptical donor stereoscopically assisted micrografting as an approach to further refinement in hair transplantation. J Dermatol Surg Oncol 20:789–793CrossRefPubMed
48.
Marzola M Trichophytic closure of the donor area. Hair Transplant Forum Int 2005:113–116
49.
Mayer ML, Perez-Meza D (2001) Managing the donor area to minimize scarring. Int J Cosmet Surg Aesthet Dermatol 3:121–126CrossRef
50.
Harris JA (2013) Follicular unit extraction. Facial Plast Surg Clin 21:375–384CrossRef
51.
International Society of Hair Restoration Surgery (2011) Practice census results, July 2011
52.
Swerdloff J, Kabaker S (1999) The state of the art: donor site harvest, graft yield estimation, and recipient site preparation for follicular-unit hair transplantation. Arch Facial Plast Surg 1:49–52CrossRefPubMed
53.
Cole J (2011) Body to scalp in hair transplantation Hair Transplantation. Informa Healthcare, London, pp 304–306
54.
Harris JA (2006) New methodology and instrumentation for follicular unit extraction: lower follicle transection rates and expanded patient candidacy. Dermatol Surg 32:56–62CrossRefPubMed
55.
Harris J (2012) CASE REPORT-robotic-assisted follicular unit extraction for hair restoration. Cosmet Dermatol 25:284
56.
Harris J The SAFE system: new instrumentation and methodology to improve follicular unit extraction (FUE). Hair Transplant Forum Int 2004:163
57.
Rassman WR, Bernstein RM, McClellan R, Jones R, Worton E, Uyttendaele H (2002) Follicular unit extraction: minimally invasive surgery for hair transplantation. Dermatol Surg 28:720–728PubMed
58.
Harris J (2010) Powered blunt dissection with the SAFE system for FUE (part I and II). Hair Transplant Forum Int 20:188–189
59.
Bernstein RM, Wolfeld MB (2016) Robotic follicular unit graft selection. Dermatol Surg 42:710–714CrossRefPubMed
60.
Bernstein RM, Rassman WR (1999) The logic of follicular unit transplantation. Dermatol Clin 17:277–296CrossRefPubMed
61.
Bernstein RM Integrating robotic FUE into a hair transplant practice Hair Transplant Forum Intl 2012:228–229
62.
Avram MR (2005) Polarized light-emitting diode magnification for optimal recipient site creation during hair transplant. Dermatol Surg 31:1124–1127CrossRefPubMed
63.
Salanitri S, Gonçalves AJ, Helene A Jr, Junqueira Lopes FH (2009) Surgical complications in hair transplantation: a series of 533 procedures. Aesthet Surg J 29:72–76CrossRefPubMed
64.
Lam SM (2013) Complications in hair restoration. Facial Plast Surg Clin 21:675–680CrossRef
65.
Konior RJ (2013) Complications in hair-restoration surgery. Facial Plast Surg Clin 21:505–520CrossRef
66.
Langtry JA, Maddin WS, Carruthers JA, Rivers JK (1998) Is there a rationale for the drugs used in hair transplantation surgery? Dermatol Surg 24:967–971PubMed
67.
68.
Singh G (1998) Effect of minoxidil on hair transplantation in alopecia androgenetica. Indian J Dermatol Venereol Leprol 64:23–24PubMed
Metadata
Title
Alopecia and techniques in hair restoration: an overview for the cosmetic surgeon
Authors
Rohan Joshi
Tom Shokri
Austin Baker
Scott Kohlert
Mofiyinfolu Sokoya
Sameep Kadakia
Jeffrey Epstein
Yadranko Ducic
R. Michael Johnson
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Oral and Maxillofacial Surgery / Issue 2/2019
Print ISSN: 1865-1550
Electronic ISSN: 1865-1569
DOI
https://doi.org/10.1007/s10006-019-00750-9

Other articles of this Issue 2/2019

Oral and Maxillofacial Surgery 2/2019 Go to the issue

Original Article

Anteroposterior and vertical soft tissue cephalometric norms of Iranians, interethnic comparisons, sex dimorphism, and the effect of age on cephalometric variables

Original Article

Psychological profiles in patients undergoing orthognathic surgery or rhinoplasty: a preoperative and preliminary comparison

Original Article

Is 0.75% ropivacaine more efficacious than 2% lignocaine with 1:80,000 epinephrine for IANB in surgical extraction of impacted lower third molar?

Original Article

Accuracy and outcome of mandibular fracture reduction without and with an aid of a repositioning forceps

Original Article

Vertically unstable fractured mandibular segment with attached genial tubercles as a parameter for difficulty during intubation for general anaesthesia—substantiation with computed tomographic (CT) scan evidence

Original Article

Ultrasound-guided arthrocentesis using single-puncture, double-lumen, single-barrel needle for patients with temporomandibular joint acute closed lock internal derangement